TESSA MILLER: Open Payments
NPI 1497320170 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$631 in 37 payments from 21 companies in 2025. Trend: 2023 $490 · 2024 $923 · 2025 $631
Food & beverage: $631
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $93 |
| Collegium Pharmaceutical, Inc. | 3 | $63 |
| Astellas Pharma US Inc | 2 | $55 |
| ABBVIE INC. | 3 | $47 |
| Corium, LLC | 4 | $46 |
| Exact Sciences Corporation | 3 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| PFIZER INC. | 2 | $31 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
Products named: Jornay PM, Veozah, VRAYLAR, Azstarys, The Cologuard Plus Collection Kit, Saxenda, Rybelsus, INGREZZA.
Industry payments across IN — which companies pay providers there.
